
Odaberite svoju etiketu
prikazano izravno na bočiciARA-290
Healing
- Šalje se iz Njemačke
Narudžba
- DHL s praćenjem
- Diskretno pakiranje
Na prvi pogled
ARA-290 u brojkama
Ključni podaci iz našeg leksikona.
Cijeli članak u leksikonu- Class
- EPO-derived peptidenon-hematopoietic
- Half-life
- short
- Use
- Subcutaneousin mg
- Sizes
- 10 to 16 mg2 sizes in the shop
What studies show
The source in the lexicon- Heij, Brines et al., Molecular Medicine, 2012
Za ARA-290 još nema laboratorijske analize. Glasaj za toDajte sami na testiranje, mi plaćamo polaSve laboratorijske analize
Znanje
Sve o ARA-290
Detaljne informacije uskoro.
Doziranje
Učitavanje podataka o doziranju …
Dobro je imati
Što vam uz to treba
Bakteriostatska voda automatski se dodaje u košaricu. Štrcaljke i maramice jednim klikom.
Inzulinske štrcaljke
10 kom. · 5.50 €
Alkoholne maramice
50 kom. · 10 €
Koliko vode?
Jedinice na štrcaljki za veličinu vaše bočice.
Otvori kalkulator →What is ARA-290?
A small peptide with the drug name cibinetide, designed from the structure of erythropoietin. Unlike EPO it is meant not to make the body form red blood cells. It acts through the innate repair receptor, a complex of the EPO receptor and CD131.
What do the sarcoidosis studies show?
In the first pilot study with 22 participants the symptom score fell by 11.5 points after 4 weeks versus 2.9 with placebo. A second study with daily dosing under the skin for 28 days found fewer symptoms, more nerve fibres in the cornea and a longer walking distance. In the phase 2b trial with 64 participants only the middle study dose was significant.
What about type 2 diabetes?
In a phase 2 trial with daily dosing under the skin for 28 days long-term blood sugar and blood lipids improved over 56 days and so did nerve pain symptoms. In participants with clearly reduced corneal nerve fibre density this density increased, with placebo it did not.
Does ARA-290 help with eye diseases?
In diabetic macular oedema a small study with 9 participants showed no improvement in visual acuity or retinal thickness after 12 weeks. Only the visual function questionnaire came out slightly better. The trial ended early because the study drug expired.
Does ARA-290 affect mood?
In a study with 36 healthy people the brain responded more weakly to happy faces one week after dosing and attention to positive pictures increased. ARA-290 had no effect on mood or emotional state. A clear antidepressant-like profile did not emerge.
Which side effects are known?
No safety concerns appeared in the studies. In diabetic macular oedema there were no serious side effects and no antibodies against the compound after 12 weeks. The abstracts give no percentages for individual side effects.
Povezano
Srodni proizvodi
BPC-157
Peptidi · Cijeljenje i oporavak Cijeljenje i oporavak
4 veličine
Laboratorijski testirano
= od 5.2 €/bočica
TB-500 (Thymosin B4)
Peptidi · Cijeljenje i oporavak Cijeljenje i oporavak
3 veličine
Laboratorijski testirano
= od 18.8 €/bočica
TB-500 FRAG
Peptidi · Cijeljenje i oporavak Cijeljenje i oporavak
1 veličina
= 24.8 €/bočica
BPC + TB Blend
Peptidi · Cijeljenje i oporavak Cijeljenje i oporavak
3 veličine
Laboratorijski testirano
= od 24.8 €/bočica
ARA-290